There have been nine reports of sensorineural hearing loss after measles, mumps, and rubella (MMR) immunisation. In three cases the deafness was unrelated to MMR immunisation. In six cases the cause was unknown and MMR remained a possible aetiology. Any risk associated with attenuated viruses must be weighed against the risks of the natural diseases. (Arch Dis Child 1993; 69: 153-154) Measles, mumps, and rubella (MMR) immunisation was introduced in the UK in October 1988. To date six million doses of vaccine have been distributed. Phase II clinical trials had shown that the adverse effects were similar in type and frequency to the measles alone vaccine.
Measles, mumps, and rubella (MMR) immunisation was introduced in the UK in October 1988. To date six million doses of vaccine have been distributed. Phase II clinical trials had shown that the adverse effects were similar in type and frequency to the measles alone vaccine. I However, rare events may not be detected by these trials. In 1988, a Danish case of unilateral deafness after MMR was reported2 and a bilateral case has subsequently been described. 3 In both cases the mumps component was considered to be causal. The other components of MMR have also been implicated in case reports. 4 The yellow card scheme was introduced in 1964 and has an important role in surveillance after marketing. It covers the whole of the UK and there are specific instructions for reporting for both new 
